Nobelprize.org
Lists of Nobel Prizes and Laureates


The AstraZeneca Nobel Medicine Initiative is a co-operation between AstraZeneca and Nobel Media. The aim of the Initiative is to increase the general public's understanding of and interest in the achievements of the Nobel Laureates within the fields of Physiology or Medicine and to further explain the benefits of the discoveries made.

The AstraZeneca Nobel Medicine Initiative is devoted to creating a diverse range of content, which explores the science and the stories behind the recipients of the Nobel Prize in Physiology or Medicine. Content consists of three core elements:

 

Images related to the AstraZeneca Nobel Medicine Initiative

 

AstraZeneca

AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialisation of prescription medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information please visit: www.astrazeneca.com.

 

Share this:
To cite this page
MLA style: "AstraZeneca Nobel Medicine Initiative". Nobelprize.org. Nobel Media AB 2014. Web. 17 Sep 2014. <http://www.nobelprize.org/nobel_organizations/nobelmedia/s_partners/astrazeneca/index.html>

Recommended:

On 27 November 1895 Alfred Nobel signed his last will in Paris.

 

Try to save some patients and learn about human blood types!

 

Discover the 2012 awarded research on stem cells and cell signalling.